Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of Iloprost in subjects
that have Pulmonary Arterial Hypertension who are concurrently taking bosentan (Tracleer TM).